Status:
COMPLETED
Neoadjuvant Chemotherapy in Cervical Cancer
Lead Sponsor:
Banaras Hindu University
Conditions:
Cervix Cancer
Cervical Cancer
Eligibility:
FEMALE
18-100 years
Phase:
PHASE3
Brief Summary
Cervical cancer represents the second commonest cancer in women worldwide, with 500,000 new cases and 300,000 deaths reported yearly. Among cervical cancer cases, 80% occur in developing countries and...
Detailed Description
This is a single group prospective study to evaluate factors affecting treatment responses in uterine cervical carcinoma. All patients who will be receiving NAC followed by surgery will be included an...
Eligibility Criteria
Inclusion
- • All patients receiving NACT followed by Surgery/RT and willing to give consent will be included in study
- FIGO Stage Ib/ IIa/ IIb
- Age more than 18 yrs
Exclusion
- • FIGO Stage Ia/ III/ IV
- Patients who received treatment earlier
- Pregnant/ lactating women
- Second primary cancer
Key Trial Info
Start Date :
August 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 31 2022
Estimated Enrollment :
33 Patients enrolled
Trial Details
Trial ID
NCT05384366
Start Date
August 1 2020
End Date
March 31 2022
Last Update
May 20 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Banaras Hindu University
Varanasi, Uttar Pradesh, India, 221005